The Use of Extracorporeal Liver Support Systems In Acute Decompensated Liver Failure

The aim of the study: to evaluate the efficacy of extracorporeal liver support systems in patients with acute liver failure of various etiologies.

Material and methods. The study included 117 patients with acute liver failure of various etiologies. The main group consisted of 71 patients who received complex intensive therapy, including MARS-therapy and hemodiafiltration. The comparison group included 46 patients who received albumin dialysis (24 patients) and hemodiafiltration (22 patients) alone. The mean age of the patients was 34±5.6 years, the majority (56.4%) were men. Dynamic assessment of patients' severity was performed using Sequential Organ Failure Assessment (SOFA) and Model for End-Stage Liver Disease (MELD) scales.

Results. A more significant reduction of SOFA and MELD scores was noted as early as by day 10 of intensive therapy in the main group with sequential use of extracorporeal liver detoxification methods — to 2.7±0.2 vs. 8.3±0.5 points (P=0.021) on SOFA and to 16.7±0.4 vs. 23.4±1.4 points (P=0.023) MELD scales. The use of a comprehensive approach to extracorporeal detoxification in acute decompensated liver failure increased the regression rate of multiple organ failure from 51.2 to 74.6% and reduced mortality from 47.8 to 25.4% (χ²=6.266; d_f=1; P=0.013). At the same time, the cumulative proportion of survivors depending on the type of complication within 30 days was 88.4% in the main group and 69.0% in the comparison group (χ²=4.164; d_f=1; P=0.042).

Conclusion. A comprehensive approach to extracorporeal detoxification is highly effective, providing a more significant reduction of SOFA and MELD scores, increasing the proportion of regression of multiple organ dysfunction and reducing mortality.

1. Grek A., Arasi L. Acute Liver Failure. AACN Adv Crit Care. 2016; 27 (4): 420–429. DOI: 10.4037/aacnacc2016324

2. Naghavi M., Abajobir A.A., Abbafati C., Abbas K.M., Abd-Allah F., Abera S.F. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390 (10100): 1151–1210. DOI: 10.1016/S0140-6736(17)32152-9.

3. Arroyo V., Jalan R. Acute-on-Chronic Liver Failure: Definition, Diagnosis, and Clinical Characteristics. Semin Liver Dis. 2016; 36 (2): 109–116. DOI: 10.1055/s-0036-1583202

4. Bower W.A., Johns M., Margolis H.S., Williams I.T., Bell B.P. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007; 102 (11): 2459–2463. DOI: 10.1111/j.1572-0241.2007.01388.x.

5. Bernal W., Hyyrylainen A., Gera A., Audimoolam V.K., McPhail M.J., Auzinger G., Rela M., Heaton N., O’Grady J.G., Wendon J., Williams M. Lessons from look-back in acute liver failure? A single Centre experience of 3300 patients. J Hepatol. 2013; 59 (1): 74–80. DOI: 10.1016/j.jhep.2013.02.010.

6. Danilov I.A., Ovechkin A.M. Multiorgan Dysfunction: the State-of-the-Art and Current Approaches to Its Treatment Using Low FlowRate Membrane Technologies. Obshchaya Reanimatologiya=General Reanimatology. 2011; 7 (6): 66. [In Russ.] DOI: 10.15360/1813-9779-2011-6-66

7. Nazyrov F.G., Ibadov R.A., Devyatov A.V., Khashimov S.Kh., Gizatulina N.R., Babadzhanov A.Kh. Therapeutic and Diagnostic Tactics for Bleedings from Esophagogastric Varices. Obshchaya Reanimatologiya=General Reanimatology. 2010; 6 (5): 46. [In Russ.] DOI: 10.15360/1813-9779-2010-5-46

8. Lodes U., Jacob D., Meyer F. Acute Liver Failure, Acute-On-Chronic Liver Failure, Hepatorenal Syndrome, Hepatopulmonary Syndrome and Portopulmonary Hypertension, Artificial Liver Support on the ICU. Zentralbl Chir. 2017; 142 (3): 275–286. DOI: 10.1055/s-0043-106198

9. Khoroshilov S.E., Nikulin A.V. Detoxication in Critical Conditions: an Insight into the Scientific Problem in the XXI Century (Review). Obshchaya Reanimatologiya=General Reanimatology. 2017; 13 (5): 85–108. [In Russ.] DOI: 10.15360/1813-9779-2017-5-85-108

10. Bernal W., Lee W.M., Wendon J., Larsen F.S., Williams R. Acute liver failure: A curable disease by 2024? J Hepatol. 2015; 62 (1 Suppl): S112–S120. DOI: 10.1016/j.jhep.2014.12.016

11. Yeremeyeva L.F., Yampolsky A.F., Zabolotskikh I.B., Menshchikov V.V. The Hemostasis System During MARS Therapy and Plasma Sorption in Patients with Liver Cell Failure. Obshchaya Reanimatologiya=General Reanimatology. 2010; 6 (5): 35. [In Russ.] DOI: 10.15360/1813-9779-2010-5-35

12. Ismailov E.L., Eralina S.N., Tekesbaev B.B., Abdrasulov R.B. Extracorporeal Detoxification Methods in the Treatment of Destructive Pancreatitis. Obshchaya Reanimatologiya=General Reanimatology. 2015; 11 (3): 65–74. [In Russ.] DOI: 10.15360/1813-9779-2015-3-65-74

13. Yampolsky M.A., Zabolotskikh I.B., Yampolsky A.F. The Elimination of Low-Molecular-Weight Proteins in Patients with Isolated Acute Renal Failure. Obshchaya Reanimatologiya=General Reanimatology. 2010; 6 (5): 40. [In Russ.] DOI: 10.15360/1813-9779-2010-5-40

14. Larsen F.S. Artificial liver support in acute and acute-on-chronic liver failure. Curr Opin Crit Care. 2019; 25 (2): 187–191. DOI: 10.1097/MCC.0000000000000584.

15. Tsipotis E., Shuja A., Jaber B.L. Albumin Dialysis for Liver Failure: A Systematic Review. Adv Chronic Kidney Dis. 2015; 22 (5): 382–390. DOI: 10.1053/j.ackd.2015.05.004

16. García Martínez J.J., Bendjelid K. Artificial liver support systems: what is new over the last decade? Ann Intensive Care. 2018; 8 (1): 109. Published 2018 Nov 15. DOI: 10.1186/s13613-018-0453-z

17. Warrillow S. Life on MARS? Crit Care Med. 2017; 45 (10): 1776–1777. DOI: 10.1097/CCM.0000000000002604.

18. Villarreal J.A., Sussman N.L. Extracorporeal Liver Support in Patients with Acute Liver Failure. Tex Heart Inst J. 2019; 46 (1): 67–68. Published 2019 Feb 1. DOI: 10.14503/THIJ-18-6744

19. Wiesmann T., Hoenl D., Wulf H., Irqsusi M. Extracorporeal liver support: trending epidemiology and mortality — a nationwide database analysis 2007–2015. BMC Gastroenterol. 2019; 19 (1): 160. Published 2019 Sep 3. DOI: 10.1186/s12876-019-1077-y

20. Karvellas C.J., Subramanian R.M. Current Evidence for Extracorporeal Liver Support Systems in Acute Liver Failure and Acute-on-Chronic Liver Failure. Crit Care Clin. 2016; 32 (3): 439–451. DOI: 10.1016/j.ccc.2016.03.003

21. MacDonald A.J., Karvellas C.J. Emerging Role of Extracorporeal Support in Acute and Acute-on-Chronic Liver Failure: Recent Developments. Semin Respir Crit Care Med. 2018; 39 (5): 625–634. DOI: 10.1055/s-0038-1675334

22. Sussman N.L., Kelly J.H. Artificial liver. Clin Gastroenterol Hepatol. 2014; 12 (9): 1439–1442. DOI: 10.1016/j.cgh.2014.06.002

23. He Y.T., Qi Y.N., Zhang B.Q., Li J.B., Bao J. Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature. World J Gastroenterol. 2019; 25 (27): 3634–3648. DOI: 10.3748/wjg.v25.i27.3634

24. Gerlach J.C. Extracorporeal Mass Exchange Technology Platform for Temporary Liver Support: A Clinical Feasibility Study on a Device and the Cell Source Primary Human Liver Cells. Surgical Case Reports. 2019; 2 (3): 2–4. DOI: 10.31487/j.SCR.2019.03.07

25. Sen S., Davies N.A., Mookerjee R.P., Cheshire L.M., Hodges S.J., Williams R., Jalan R. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl. 2004; 10 (9): 1109–1119. DOI: 10.1002/lt.20236

26. Donati G., La Manna G., Cianciolo G., Grandinetti V., Carretta E., Cappuccilli M., Panicali L., Iorio M., Piscaglia F., Bolondi L., Colì L., Stefoni S. Extracorporeal detoxification for hepatic failure using molecular adsorbent recirculating system: depurative efficiency and clinical results in a long-term follow-up. Artif Organs. 2014; 38 (2): 125–134. DOI: 10.1111/aor.12106